Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 7 | |
Outperform | 9 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 14 analysts offering 12 month price targets for Immunovant Inc have a median target of 50.00, with a high estimate of 58.00 and a low estimate of 36.00. The median estimate represents a 88.39% increase from the last price of 26.54.
High | 118.5% | 58.00 |
Med | 88.4% | 50.00 |
Low | 35.6% | 36.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Jan 31, 2025.
Average growth rate | -15.79% |
Average growth rate | -6.49% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼